[6, 7] Despite the fact that it is repeatedly shown that IL-6 is important in MM cell survival both in vitro and in vivo, treatment blocking IL-6 signaling has so far not proven to be an efficient approach. This evidence concerns the gene IL6 and Miyoshi myopathy.